Efficacy and Safety of the Use of Venocur Triplex® in Patients With Chronic Venous Insufficiency
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the therapeutic efficacy and safety of Venocur
Triplex®, administered BID for 60 days in patients with Chronic Venous Insufficiency rated
between CEAP 2 and 4, in comparison to a Placebo group.